Torigen Pharmaceuticals, Inc. produces an experimental Autologous Prescription Product regulated by the USDA Center for Veterinary Biologics. For use under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.
Torigen Pharmaceuticals, Inc. produces an experimental Autologous Prescription Product regulated by the USDA Center for Veterinary Biologics. For use under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.
Torigen Pharmaceuticals, Inc. produces an experimental Autologous Prescription Product regulated by the USDA Center for Veterinary Biologics. For use under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.
Our Company
Our Company
Our Company
Torigen was formed to bring hope and improve the quality of life for pets facing a cancer or an autoimmune diagnosis.
Torigen was formed to bring hope and improve the quality of life for pets facing a cancer or an autoimmune diagnosis.
Founded by Dr. Mark Suckow and Ashley Kalinauskas, MS with technology from the University of Notre Dame, they embarked on a mission to bring this novel cancer vaccine to the veterinary market. Starting with just a single lab, they've built one of the most exciting companies in animal health and have expanded outside of oncology to further help pets with diseases of the immune system.
Founded by Dr. Mark Suckow and Ashley Kalinauskas, MS with technology from the University of Notre Dame, they embarked on a mission to bring this novel cancer vaccine to the veterinary market. Starting with just a single lab, they've built one of the most exciting companies in animal health and have expanded outside of oncology to further help pets with diseases of the immune system.
We bring the most advanced therapeutics to the veterinary market.
We bring the most advanced therapeutics to the veterinary market.
Our pets deserve the best. We brought together a leading team of expert researchers and veterinary oncologists, led by our Chief Medical Officer, Dr. Mike Lucroy, MS, DVM, DACVIM(O) and our Vice President of Veterinary Affairs, Dr. Chelsea Greenberg MS, DVM, DACVIM(O). Dr. Ryan Clauson, PhD is our incredible Chief Innovation Officer with a background in cancer immunotherapeutics and pharmaceutical sciences.
Our pets deserve the best. We brought together a leading team of expert researchers and veterinary oncologists, led by our Chief Medical Officer, Dr. Mike Lucroy, MS, DVM, DACVIM(O) and our Vice President of Veterinary Affairs, Dr. Chelsea Greenberg MS, DVM, DACVIM(O). Dr. Ryan Clauson, PhD is our Chief Innovation Officer and leads our R&D team with a background in cancer immunotherapeutics and pharmaceutical sciences.
Torigen was formed to bring hope and improve the quality of life for pets facing a cancer or autoimmune diagnosis.
Founded by Dr. Mark Suckow and Ashley Kalinauskas, MS with technology from the University of Notre Dame, they embarked on a mission to bring this novel cancer vaccine to the veterinary market.
*Coming Soon*
*Coming Soon*
Torigen Speciality Pathology is launching in November, 2024. We have brought together three of the world's leading veterinary pathologists to provide actionable diagnoses and unparalleled access to world renowned experts.
We bring the most advanced therapeutics to the veterinary market.
Our pets deserve the best. We brought together a leading team of expert researchers and veterinary oncologists, led by our Chief Medical Officer, Dr. Mike Lucroy, MS, DVM, DACVIM(O) and our Vice President of Veterinary Affairs, Dr. Chelsea Greenberg MS, DVM, DACVIM(O). Dr. Ryan Clauson, PhD is our Chief Innovation Officer and leads our R&D team with a background in cancer immunotherapeutics and pharmaceutical sciences.
Get started with Torigen today.
Get started with Torigen today.
Get started with Torigen today.
Harnessing the Immune System to
Fight Cancer
Specialty Pathology
Personalized Therapeutics
